{rfName}
Cl

Altmetrics

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Marco Hernandez, JavierOthersSeguí EAuthorGarcia-Fructuoso, IAuthorFerrante, DAuthor

Share

August 13, 2020
Publications
>
Article
No

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

Publicated to: Cancer Discovery. 10 (10): 1465-1474 - 2020-10-01 10(10), DOI: 10.1158/2159-8290.cd-20-0773

Authors:

Pinato, David J; Zambelli, Alberto; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C T; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Mesia, Ricard; Segui, Elia; Biello, Federica; Generali, Daniele; Grisanti, Salvatore; Rizzo, Gianpiero; Libertini, Michela; Maconi, Antonio; Harbeck, Nadia; Vincenzi, Bruno; Bertulli, Rossella; Ottaviani, Diego; Carbo, Anna; Bruna, Riccardo; Benafif, Sarah; Marrari, Andrea; Wuerstlein, Rachel; Carmona-Garcia, M Carmen; Chopra, Neha; Tondini, Carlo; Mirallas, Oriol; Tovazzi, Valeria; Betti, Marta; Provenzano, Salvatore; Fotia, Vittoria; Cruz, Claudia Andrea; Dalla Pria, Alessia; D'Avanzo, Francesca; Evans, Joanne S; Saoudi-Gonzalez, Nadia; Felip, Eudald; Galazi, Myria; Garcia-Fructuoso, Isabel; Lee, Alvin J X; Newsom-Davis, Thomas; Patriarca, Andrea; Garcia-Illescas, David; Reyes, Roxana; Dileo, Palma; Sharkey, Rachel; Wong, Yien Ning Sophia; Ferrante, Daniela; Marco-Hernandez, Javier; Sureda, Anna; Maluquer, Clara; Ruiz-Camps, Isabel; Gaidano, Gianluca; Rimassa, Lorenza; Chiudinelli, Lorenzo; Izuzquiza, Macarena; Cabirta, Alba; Franchi, Michela; Santoro, Armando; Prat, Aleix; Tabernero, Josep; Gennari, Alessandra
[+]

Affiliations

ASST Cremona, Multidisciplinary Breast Pathol & Translat Res Un, Cremona, Italy - Author
ASST Papa Giovanni XXIII, Oncol Unit, Bergamo, Italy - Author
Azienda Osped SS Antonio & Biagio & Cesare Arrigo, Infrastruttura Ric Formaz Innovaz, Alessandria, Italy - Author
Catalan Inst Oncol, Dept Med Oncol, Badalona, Spain - Author
Chelsea & Westminster Hosp, Dept Oncol, London, England - Author
Chelsea & Westminster Hosp, Natl Ctr HIV Malignancy, London, England - Author
CIBERONC, Oncobell Program IDIBELL, Dept Med Oncol, ICO Hosp, Barcelona, Spain - Author
CPO Piemonte, Canc Epidemiol, Novara, Italy - Author
Fdn IRCCS Ist Nazl Tumori, Milan, Italy - Author
Fdn IRCCS Policlin San Matteo, Med Oncol Unit, Pavia, Italy - Author
Fdn Poliambulanza Ist Osped, Med Oncol Unit, Brescia, Italy - Author
Hosp Clin Barcelona, Dept Internal Med, Barcelona, Spain - Author
Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain - Author
Humanitas Clin & Res Ctr IRCCS, Med Oncol & Hematol Unit, Humanitas Canc Ctr, Milan, Italy - Author
Humanitas Univ, Dept Biomed Sci, Milan, Italy - Author
IDIBAPS, Translat Genom & Targeted Therapies Solid Tumors, Barcelona, Spain - Author
Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, London, England - Author
Inst Oncol VHIO, Barcelona, Spain - Author
Maggiore Carita Hosp, Novara, Italy - Author
Policlin Univ Campus Biomed, Rome, Italy - Author
Spedali Civil Brescia, Med Oncol Unit, Brescia, Italy - Author
Univ Barcelona, Haematol Dept, ICO Hosp, IDIBELL, Barcelona, Spain - Author
Univ Coll London Hosp, Canc Div, London, England - Author
Univ Hosp Josep Trueta, Catalan Inst Oncol, Dept Med Oncol, Girona, Spain - Author
Univ Hosp Munich, CCC Munich, Munich, Germany - Author
Univ Hosp Munich, Dept Gynecol & Obstet, Breast Ctr, Munich, Germany - Author
Univ Hosp Munich, Gynecol Canc Ctr, Munich, Germany - Author
Univ Piemonte Orientale, Dept Translat Med, Div Oncol, Novara, Italy - Author
Univ Piemonte Orientale, Dept Translat Med, Unit Med Stat, Novara, Italy - Author
Univ Piemonte Orientale, Div Haematol, Dept Translat Med, Novara, Italy - Author
Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy - Author
Vall dHebron Univ Hosp, Dept Haematol, Barcelona, Spain - Author
Vall dHebron Univ Hosp, Infect Dis, Barcelona, Spain - Author
Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain - Author
See more

Abstract

The SARS-Cov-2 pandemic significantly impacted on oncology practice across the globe. There is uncertainty as to the contribution of patients' demographics and oncological features on severity and mortality from Covid-19 and little guidance as to the role of anti-cancer and anti-Covid-19 therapy in this population. In a multi-center study of 890 cancer patients with confirmed Covid-19 we demonstrated a worsening gradient of mortality from breast cancer to haematological malignancies and showed that male gender, older age, and number of co-morbidities identifies a subset of patients with significantly worse mortality rates from Covid-19. Provision of chemotherapy, targeted therapy and immunotherapy did not worsen mortality. Exposure to antimalarials was associated with improved mortality rates independent of baseline prognostic factors. This study highlights the clinical utility of demographic factors for individualized risk-stratification of patients and support further research into emerging anti-Covid-19 therapeutics in SARS-Cov-2 infected cancer patients.Copyright ©2020, American Association for Cancer Research.
[+]

Keywords

Good health and well-being

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Cancer Discovery due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2020, it was in position 6/242, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 6.87. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 13, 2025)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 7.06 (source consulted: FECYT Mar 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2026-04-05, the following number of citations:

  • WoS: 156
  • Scopus: 156
  • Europe PMC: 126
  • Open Alex: 169
[+]

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2026-04-05:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 195.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 195 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 592.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 1953 (Altmetric).
  • The number of mentions in news outlets: 4 (Altmetric).
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 3 - Good Health And Well-being, with a probability of 90% according to the mBERT algorithm developed by Aurora University.
[+]

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Germany; Italy; United Kingdom.

[+]

Awards linked to the item

D.J. Pinato is supported by grant funding from the Wellcome Trust Strategic Fund (PS3416) and acknowledges grant support from the Cancer Treatment and Research Trust (CTRT) and infrastructural support by the Cancer Research UK Imperial Centre and the NIHR Imperial Biomedical Research Centre. G. Gaidano is supported by the AIRC 5 x 1000 Grant, No. 21198, Associazione Italiana per la Ricerca sul Cancro Foundation, Milan, Italy. A. Gennari is supported by the AIRC IG Grant, No. 14230, Associazione Italiana per la Ricerca sul Cancro Foundation, Milan, Italy. A. Gennari and G. Gaidano from the University of Piemonte Orientale (Novara, Italy) acknowledge support from the UPO Aging Project. The authors would like to acknowledge the following study collaborators: Dr. Lorenza Scotti, PhD (Unit of Cancer Epidemiology, CPO-Piemonte, University of Eastern Piedmont, Novara, Italy), Professor Gian Carlo Avanzi, MD, Dr. Mattia Bellan, MD, PhD, Dr. Luigi Mario Castello, MD, PhD, Professor Mario Pirisi, MD (Divisions of Internal and Emergency Medicine, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carita' Hospital, Novara, Italy), Dr. Meritxell Molla, MD, PhD (Department of Radiation Oncology, Hospital Clinic, Barcelona, Spain), Judith Swallow and Maria Martinez (Imperial College London, Division of Surgery and Cancer). We would like to acknowledge Sara Wendy Oliva for her administrative support.
[+]